These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12769650)

  • 1. Pharmacotherapeutic approach to prevent or treat chronic allograft nephropathy.
    Scholten EM; de Fijter JW; Paul LC
    Curr Drug Targets Cardiovasc Haematol Disord; 2002 Dec; 2(2):79-96. PubMed ID: 12769650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction.
    Bedi DS; Riella LV; Tullius SG; Chandraker A
    Transplantation; 2010 Nov; 90(9):935-44. PubMed ID: 20703180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic allograft rejection.
    Häyry P; Isoniemi H; Yilmaz S; Mennander A; Lemström K; Räisänen-Sokolowski A; Koskinen P; Ustinov J; Lautenschlager I; Taskinen E
    Immunol Rev; 1993 Aug; 134():33-81. PubMed ID: 8225374
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive treatment and progression of histologic lesions in kidney allografts.
    Morales JM
    Kidney Int Suppl; 2005 Dec; (99):S124-30. PubMed ID: 16336565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of chronic heart and kidney allograft rejection.
    Paul LC
    Transplant Proc; 1993 Apr; 25(2):2080-1. PubMed ID: 8470277
    [No Abstract]   [Full Text] [Related]  

  • 6. Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
    Yilmaz S; Taskinen E; Häyry P; Isoniemi H
    Transplant Proc; 1996 Feb; 28(1):491-3. PubMed ID: 8644324
    [No Abstract]   [Full Text] [Related]  

  • 7. Allograft de novo membranous nephropathy complicating Alport's syndrome.
    Prasad GV; Sweet JM; Cole EH; Cardella CJ
    Nephron; 2000 Oct; 86(2):227. PubMed ID: 11015013
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
    Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E
    Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology.
    Solez K; Benediktsson H; Cavallo T; Croker B; Demetris AJ; Drachenberg C; Emancipator S; Furness PN; Gaber LW; Gibson IW; Gough J; Gupta R; Halloran P; Häyry P; Kashgarian M; Marcussen N; Massy ZA; Mihatsch MJ; Morozumi K; Noronha I; Olsen S; Papadimitriou J; Paul LC; Picken M; Racusen LC; Ramos EL; Randhawa P; Rayner DC; Rush D; Sanfilippo F; Taskinen E; Trpkov K; Truong L; Yamaguchi Y; Yilmaz S
    Transplant Proc; 1996 Feb; 28(1):441-4. PubMed ID: 8644308
    [No Abstract]   [Full Text] [Related]  

  • 12. Protocol biopsies after kidney transplantation.
    Böhmig GA; Regele H; Hörl WH
    Transpl Int; 2005 Feb; 18(2):131-9. PubMed ID: 15691264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia reperfusion injury and chronic allograft rejection.
    Szabo A; Heemann U
    Transplant Proc; 1998 Dec; 30(8):4281-4. PubMed ID: 9865363
    [No Abstract]   [Full Text] [Related]  

  • 14. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
    Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent or persistent cardiac allograft rejection: therapeutic options and recommendations.
    Kirklin JK; Bourge RC; McGiffin DC
    Transplant Proc; 1997 Dec; 29(8A):40S-44S. PubMed ID: 9414674
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection.
    McGrath JS; Shehata M
    Transplant Proc; 2001 May; 33(3):2191-2. PubMed ID: 11377499
    [No Abstract]   [Full Text] [Related]  

  • 17. New insights in chronic allograft rejection.
    Paul LC
    Curr Opin Urol; 2002 Mar; 12(2):89-93. PubMed ID: 11859253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and molecular mechanisms of chronic allograft nephropathy.
    Ahsan N; Cheung JY
    Contrib Nephrol; 2003; 139():187-204. PubMed ID: 12854326
    [No Abstract]   [Full Text] [Related]  

  • 19. Overcoming Chronic Rejection-Can it B?
    Kwun J; Knechtle SJ
    Transplantation; 2009 Oct; 88(8):955-61. PubMed ID: 19855237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft mucormycosis in a renal allograft recipient.
    Ahmad M
    J Nephrol; 2005; 18(6):783-6. PubMed ID: 16358241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.